Cargando…
Comprehensive genomic profiling identifies a novel TNKS2–PDGFRA fusion that defines a myeloid neoplasm with eosinophilia that responded dramatically to imatinib therapy
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349257/ https://www.ncbi.nlm.nih.gov/pubmed/25658984 http://dx.doi.org/10.1038/bcj.2014.95 |
| _version_ | 1782360018707808256 |
|---|---|
| author | Chalmers, Z R Ali, S M Ohgami, R S Campregher, P V Frampton, G M Yelensky, R Elvin, J A Palma, N A Erlich, R Vergilio, J-A Chmielecki, J Ross, J S Stephens, P J Hermann, R Miller, V A Miles, C R |
| author_facet | Chalmers, Z R Ali, S M Ohgami, R S Campregher, P V Frampton, G M Yelensky, R Elvin, J A Palma, N A Erlich, R Vergilio, J-A Chmielecki, J Ross, J S Stephens, P J Hermann, R Miller, V A Miles, C R |
| author_sort | Chalmers, Z R |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4349257 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-43492572015-03-10 Comprehensive genomic profiling identifies a novel TNKS2–PDGFRA fusion that defines a myeloid neoplasm with eosinophilia that responded dramatically to imatinib therapy Chalmers, Z R Ali, S M Ohgami, R S Campregher, P V Frampton, G M Yelensky, R Elvin, J A Palma, N A Erlich, R Vergilio, J-A Chmielecki, J Ross, J S Stephens, P J Hermann, R Miller, V A Miles, C R Blood Cancer J Letter to the Editor Nature Publishing Group 2015-02 2015-02-06 /pmc/articles/PMC4349257/ /pubmed/25658984 http://dx.doi.org/10.1038/bcj.2014.95 Text en Copyright © 2015 Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
| spellingShingle | Letter to the Editor Chalmers, Z R Ali, S M Ohgami, R S Campregher, P V Frampton, G M Yelensky, R Elvin, J A Palma, N A Erlich, R Vergilio, J-A Chmielecki, J Ross, J S Stephens, P J Hermann, R Miller, V A Miles, C R Comprehensive genomic profiling identifies a novel TNKS2–PDGFRA fusion that defines a myeloid neoplasm with eosinophilia that responded dramatically to imatinib therapy |
| title | Comprehensive genomic profiling identifies a novel TNKS2–PDGFRA fusion that defines a myeloid neoplasm with eosinophilia that responded dramatically to imatinib therapy |
| title_full | Comprehensive genomic profiling identifies a novel TNKS2–PDGFRA fusion that defines a myeloid neoplasm with eosinophilia that responded dramatically to imatinib therapy |
| title_fullStr | Comprehensive genomic profiling identifies a novel TNKS2–PDGFRA fusion that defines a myeloid neoplasm with eosinophilia that responded dramatically to imatinib therapy |
| title_full_unstemmed | Comprehensive genomic profiling identifies a novel TNKS2–PDGFRA fusion that defines a myeloid neoplasm with eosinophilia that responded dramatically to imatinib therapy |
| title_short | Comprehensive genomic profiling identifies a novel TNKS2–PDGFRA fusion that defines a myeloid neoplasm with eosinophilia that responded dramatically to imatinib therapy |
| title_sort | comprehensive genomic profiling identifies a novel tnks2–pdgfra fusion that defines a myeloid neoplasm with eosinophilia that responded dramatically to imatinib therapy |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349257/ https://www.ncbi.nlm.nih.gov/pubmed/25658984 http://dx.doi.org/10.1038/bcj.2014.95 |
| work_keys_str_mv | AT chalmerszr comprehensivegenomicprofilingidentifiesanoveltnks2pdgfrafusionthatdefinesamyeloidneoplasmwitheosinophiliathatrespondeddramaticallytoimatinibtherapy AT alism comprehensivegenomicprofilingidentifiesanoveltnks2pdgfrafusionthatdefinesamyeloidneoplasmwitheosinophiliathatrespondeddramaticallytoimatinibtherapy AT ohgamirs comprehensivegenomicprofilingidentifiesanoveltnks2pdgfrafusionthatdefinesamyeloidneoplasmwitheosinophiliathatrespondeddramaticallytoimatinibtherapy AT campregherpv comprehensivegenomicprofilingidentifiesanoveltnks2pdgfrafusionthatdefinesamyeloidneoplasmwitheosinophiliathatrespondeddramaticallytoimatinibtherapy AT framptongm comprehensivegenomicprofilingidentifiesanoveltnks2pdgfrafusionthatdefinesamyeloidneoplasmwitheosinophiliathatrespondeddramaticallytoimatinibtherapy AT yelenskyr comprehensivegenomicprofilingidentifiesanoveltnks2pdgfrafusionthatdefinesamyeloidneoplasmwitheosinophiliathatrespondeddramaticallytoimatinibtherapy AT elvinja comprehensivegenomicprofilingidentifiesanoveltnks2pdgfrafusionthatdefinesamyeloidneoplasmwitheosinophiliathatrespondeddramaticallytoimatinibtherapy AT palmana comprehensivegenomicprofilingidentifiesanoveltnks2pdgfrafusionthatdefinesamyeloidneoplasmwitheosinophiliathatrespondeddramaticallytoimatinibtherapy AT erlichr comprehensivegenomicprofilingidentifiesanoveltnks2pdgfrafusionthatdefinesamyeloidneoplasmwitheosinophiliathatrespondeddramaticallytoimatinibtherapy AT vergilioja comprehensivegenomicprofilingidentifiesanoveltnks2pdgfrafusionthatdefinesamyeloidneoplasmwitheosinophiliathatrespondeddramaticallytoimatinibtherapy AT chmieleckij comprehensivegenomicprofilingidentifiesanoveltnks2pdgfrafusionthatdefinesamyeloidneoplasmwitheosinophiliathatrespondeddramaticallytoimatinibtherapy AT rossjs comprehensivegenomicprofilingidentifiesanoveltnks2pdgfrafusionthatdefinesamyeloidneoplasmwitheosinophiliathatrespondeddramaticallytoimatinibtherapy AT stephenspj comprehensivegenomicprofilingidentifiesanoveltnks2pdgfrafusionthatdefinesamyeloidneoplasmwitheosinophiliathatrespondeddramaticallytoimatinibtherapy AT hermannr comprehensivegenomicprofilingidentifiesanoveltnks2pdgfrafusionthatdefinesamyeloidneoplasmwitheosinophiliathatrespondeddramaticallytoimatinibtherapy AT millerva comprehensivegenomicprofilingidentifiesanoveltnks2pdgfrafusionthatdefinesamyeloidneoplasmwitheosinophiliathatrespondeddramaticallytoimatinibtherapy AT milescr comprehensivegenomicprofilingidentifiesanoveltnks2pdgfrafusionthatdefinesamyeloidneoplasmwitheosinophiliathatrespondeddramaticallytoimatinibtherapy |